Hemofiltration-induced neuroprotection following ischemic stroke

dc.contributor.authorZhumadilov, A.
dc.contributor.authorZlotnik, A.
dc.contributor.authorGilman, C.
dc.contributor.authorViderman, D.
dc.contributor.authorUmbetzhanov, Y.
dc.contributor.authorSmagulova, B.
dc.contributor.authorKorabaev, G.
dc.contributor.authorZhumabaev, M.
dc.contributor.authorAsselbekov, Zh.
dc.contributor.authorEsenalin, N.
dc.date.accessioned2015-10-29T11:06:17Z
dc.date.available2015-10-29T11:06:17Z
dc.date.issued2013
dc.description.abstractIschemic stroke is accompanied by a three to four hundred percent increase in the brain’s extracellular fluid and cerebrospinal fluid glutamate concentration, which diffuses and damages surrounding neurons. In preclinical models of permanent middle cerebral artery occlusion, neurological outcomes correlate closely with blood or plasma glutamate levels. Previous attempts to reduce glutamate-induced excitotoxicity after stroke have included inhibition of glutamate receptors and administration of pyruvate and oxaloacetate. These strategies, including competitive and non-competitive glutamate receptor antagonists improved preclinical stroke outcomes but were without favorable outcomes or had significant unfavorable side-effects in human trials. We propose to decrease glutamate levels via an alternative mechanism, which should improve survival and neurological outcomes, without drug-induced side effects and complications. Glutamate, glutamate oxaloacetate transaminase and glutamate pyruvate transaminase concentrations are decreased during standard 4-hour long hemofiltration in chronic renal failure patients.ru_RU
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/585
dc.language.isoenru_RU
dc.publisherNazarbayev Universityru_RU
dc.subjectIschemic strokeru_RU
dc.subjecthemofiltrationru_RU
dc.subjectinnovative scientific researchru_RU
dc.titleHemofiltration-induced neuroprotection following ischemic strokeru_RU
dc.typeAbstractru_RU

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
hemofiltration.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: